News
A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...
How Australian pregnant women are tested for gestational diabetes is set to change, with new national guidelines released ...
Eli Lilly And Co.'s (LLY) investigational oral GLP-1 receptor agonist, orforglipron, demonstrated compelling efficacy and a safety profile aligned with that of injectable GLP-1 therapies, according to ...
The government issued a serious warning relating to sexual health for Mounjaro users. And tomorrow (23 June), the weight loss ...
Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...
Keke Palmer, Niecy Nash-Betts and Fantasia Barrino pose in Beverly Hills, plus MGK, America Ferrera and more. From France to ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Type 1 diabetes concept suggested by insulin syringe] adrian825 Vertex Pharmaceuticals (NASDAQ:VRTX [ has posted new data from a Phase 1/2/3 study for zimislecel (VX-880), its experimental therapy for ...
A dramatic pullback in public biotech investment catalyzed by economic and regulatory upheaval is putting even more stress on ...
Ethan Hunt's last mission? A new Superman? Happy Gilmore as a dad? Three genre-spanning Pedro Pascal movies, including a ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results